Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 Protein Vaccine - PMC Back to Top Skip
to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main …

Multimodal single-cell profiling methods can capture immune cell variations unfolding over
time at the molecular, cellular, and population levels. Transforming these data into biological …

The development of COVID-19 vaccines is critical in controlling global health issues under
the COVID-19 pandemic. The subunit vaccines are the safest and most widely used vaccine …

The majority of vaccines have been delivered into the muscular tissue. Skin contains large
amounts of antigen-presenting cells and has been recognized as a more immunogenic site …

Solid organ transplant (SOT) recipients are at increased risk of influenza disease and
associated complications. The mainstay of prevention is the annual standard-dose influenza …

The influenza pandemic is a major threat to human health, and highly aggressive strains
such as H1N1, H5N1 and H7N9 have emphasized the need for therapeutic strategies to …

The poor immunogenicity of peptide vaccines compared to conventional ones re usually
improved by applying different adjuvants. As chemical or biological substances, adjuvants …

The spread of highly pathogenic avian H5N1 influenza viruses since 1997 and their
virulence for poultry and humans has raised concerns about their potential to cause an …

The discovery and wide spread use of vaccines have saved millions of lives in the past few
decades. Vaccine adjuvants represent an integral part of the modern vaccines. Despite …

In recent decades, vaccines have been extraordinary resources to prevent pathogen
diffusion and cancer. Even if they can be formed by a single antigen, the addition of one or …